NEW YORK (GenomeWeb) – Belgian molecular diagnostics developer MDxHealth announced today that its ConfirmMDx prostate cancer test has been included as an in-network benefit under the California Medical Assistance Program (Medi-Cal).

Medi-Cal is California's state-run Medicaid program and has approximately 12 million enrollees. With the inclusion of ConfirmMDx in the program, MDxHealth said it will seek access to the test through other US Medicaid programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.